As previous studies have proved that downregulation of CAVIN2 could cause reduction in CAVIN1 and CAV1 expression (54), the interdependency of these 3 molecules makes CAVIN2 as a prominent therapeutic target in breast cancer treatment. The gene discussed is CAVIN1; the disease is breast cancer.